(Q50740968)

18 March 2018

title

Standardization of the red cell product. (English)

1 reference

18 March 2018

author name string

Joseph D Sweeney

series ordinal

1

1 reference

18 March 2018

publication date

28 February 2006

1 reference

18 March 2018

Transfusion and Apheresis Science

published in

1 reference

18 March 2018

volume

34

1 reference

18 March 2018

issue

2

1 reference

18 March 2018

page(s)

213-218

1 reference

18 March 2018

Transfusion in America in the Eighteenth and Nineteenth Centuries

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.11.006

Blood, drugs, and the United States Pharmacopeia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.11.006

Universal leukoreduction of cellular blood components in 2001? Yes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.11.006

Pathogen inactivation of labile blood products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.11.006

Transfusion to blood group A and O patients of group B RBCs that have been enzymatically converted to group O

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.11.006

Camouflaged blood cells: low-technology bioengineering for transfusion medicine?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.11.006

Early changes in hemoglobin and hematocrit levels after packed red cell transfusion in patients with acute anemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.11.006

Hb content-based transfusion policy successfully reduces the number of RBC units transfused

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.11.006

A retrospective study evaluating single-unit red blood cell transfusions in reducing allogeneic blood exposure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.11.006

Comparison of in vivo red cell survival of donations collected by Haemonetics MCS versus conventional collection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.11.006

Two-unit red cell apheresis and its potential advantages over traditional whole-blood donation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.11.006

Options and cost effectiveness of multicomponent blood collection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.11.006

Multicomponent apheresis blood collection in the United States: current status and future directions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.11.006

Storage parameters affecting red blood cell survival and function after transfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.11.006

The clinical consequences of the red cell storage lesion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.11.006

Addition of L-carnitine to additive solution-suspended red cells stored at 4 degrees C reduces in vitro hemolysis and improves in vivo viability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.11.006

Improved maintenance of 2,3 DPG and ATP in RBCs stored in a modified additive solution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.11.006

7 January 2021

RBC storage for 11 weeks

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.11.006

Alkaline CPD and the preservation of RBC 2,3-DPG.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.11.006

10.1016/J.TRANSCI.2005.11.006

7 January 2021

Identifiers

DOI

1 reference

18 March 2018

1 reference

18 March 2018